1. Mickleborough, L and Maruyama, H and Takagi, Y and Mohamed, S and Sun, Z and Ebisuzaki, L. (1995) Result of revascularization in patients with severe left ventricular dysfunction Circulation, 92, pp. II73 - II79. [PUBMED][INFOTRIEVE][CSA]
2. Pagley, P and Beller, G and Watson, D and Gimple, L and Ragosta, M. (1997) Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability Circulation, 96, pp. 793 - 800. [PUBMED][INFOTRIEVE][CSA]
3. Granger, C and Mahaffey, K and Weaver, D and Theroux, P and Hochman, J and Filloon, T and Rollins, S and Todaro, T and Nicolau, J and Ruzyllo, W and Armstrong, P. (2003) Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial Circulation, 108, pp. 1184 - 90. [PUBMED][INFOTRIEVE][CSA][CROSSREF]
4. Bax, J and Wijns, W and Cornel, J and Visser, F and Boersma, E and Fioretti, P. (1997) Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data J Amer Coll Cardiol, 30, pp. 1451 - 60. [CSA][CROSSREF]
5. Fieno, D and Kim, R and Chen, E and Lomasney, J and Klocke, F and Judd, R. (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing J Amer Coll Cardiol, 36, pp. 1985 - 91. [CSA][CROSSREF]